Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890174 · ClinicalTrials.gov registry record
Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation
A clinical trial of Dry AMD With Macular Drusen, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT01890174: Completed study of Dry AMD With Macular Drusen, sponsored by Carl Zeiss Meditec.
NCT01890174 is a study of Dry AMD With Macular Drusen that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 54 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890174, a study of Dry AMD With Macular Drusen, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.
Conditions Studied
Study Locations (1)
California
- Northern California Retina Vitreous Associates - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-06 |
What the finished NCT01890174 record still lists
NCT01890174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 1 condition, with Dry AMD With Macular Drusen appearing as the primary indexed condition, and to 0 interventions.
NCT01890174 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01890174 about?
NCT01890174 is a clinical study titled "Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation". The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.
What is the current status of trial NCT01890174?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2011-02. Estimated completion is 2011-06.
What conditions does trial NCT01890174 study?
This clinical trial studies the following conditions: Dry AMD With Macular Drusen.
Who is sponsoring clinical trial NCT01890174?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01890174 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia